Join the club for FREE to access the whole archive and other member benefits.

Medicines and Healthcare products Regulatory Agency (MHRA)

Regulates medicines, medical devices and blood components for transfusion in the UK

(MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.

The MHRA has several independent advisory committees which provide the UK Government with information and guidance on the regulation of medicines and medical devices. There are currently eight such committees.

The MHRA manages the Early Access to Medicines Scheme (EAMS), which was created in 2014 to allow access to medicines prior to market authorisation where there is a clear unmet medical need.


Visit website: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency

 mhragovuk

 medicines-and-healthcare-products-regulatory-agency

 MHRAgovuk

Details last updated 30-Apr-2022

People at Medicines and Healthcare products Regulatory Agency (MHRA)

Marc Bailey

Chief Science, Research and Innovation Officer at Medicines and Healthcare products Regulatory Agency (MHRA)

Medicines and Healthcare products Regulatory Agency (MHRA) News

UK's approval of casgevy paves the way for gene-edited treatment of blood disorders

BBC - 16-Nov-2023

Casgevy offers hope for patients with sickle cell disease and beta thalassemia

Read more...

MHRA has approved Mounjaro, a diabetes drug that promotes weight loss

GOV.UK - 08-Nov-2023

The drug works by regulating appetite and reducing cravings

Read more...

Medicinal mushrooms: A closer look at the science behind the health claims

The Guardian - 29-Oct-2023

More research is needed to confirm the health benefits of mushrooms

Read more...

MHRA-trial of new robot that can grow stem cells- to bring new low cost and safe therapies

GOV.UK - 16-Mar-2023

Fully automated Intelligent Cell Processing System to manufacture potentially life-saving treatments

Read more...

Update on successful dosing of first patient CLXR-001 by Celixir

GlobeNewswire - 06-Jul-2019

Ongoing clinical trials for heart patients with cellular therapy to cure damaged heart muscles

Read more...

Gene Therapy Trial to Restore Sight in Retinitis Pigmentosa

Labiotech - 10-Jan-2018

GenSight using gene therapy and a wearable device to restore sight in patients with retinitis pig...

Read more...